HUBSPOT INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HUBSPOT INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $144.02M | Feb 12, 2019 |
| FY2018 | Sep 30, 2018 | $131.83M | Feb 12, 2019 |
| FY2018 | Jun 30, 2018 | $122.58M | Feb 12, 2019 |
| FY2018 | Mar 31, 2018 | $114.56M | Feb 12, 2019 |
| FY2018 | Dec 31, 2017 | $106.54M | Feb 12, 2019 |
| FY2018 | Sep 30, 2017 | $97.73M | Feb 12, 2019 |
| FY2018 | Jun 30, 2017 | $89.09M | Feb 12, 2019 |
| FY2018 | Mar 31, 2017 | $82.25M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $76.44M | Feb 13, 2018 |
| FY2017 | Sep 30, 2016 | $70.59M | Feb 13, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.13B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.63B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.17B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.73B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.30B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $252.07M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $228.39M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $203.61M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $198.97M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $186.19M | Feb 16, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.62B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.83B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.42B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.04B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $204.77M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $185.78M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $164.83M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $160.68M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $150.21M | Feb 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.91M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.63M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | ($164.51M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($107.35M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($77.84M) | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | ($15.42M) | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | ($22.50M) | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | ($29.40M) | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | ($17.72M) | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | ($10.30M) | Feb 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.38M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($67.60M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | ($200.93M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($102.86M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($54.80M) | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | ($50.83M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | ($46.99M) | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | ($48.26M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | ($40.14M) | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | ($44.66M) | Feb 12, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $905.94M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $778.71M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $617.75M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $442.02M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $301.97M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $205.59M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $158.24M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $117.60M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $70.37M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $46.00M | Feb 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $760.72M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $598.60M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $350.97M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $273.17M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $238.73M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $88.91M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $118.97M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $84.85M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $49.61M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $19.37M | Feb 12, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.17M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $37.94M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $33.72M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $37.43M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $28.73M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $37.27M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $40.37M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $22.31M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $20.28M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $15.79M | Feb 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.85B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.80B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $3.07B | Feb 12, 2025 |
| FY2024 | Dec 31, 2022 | $2.54B | Feb 12, 2025 |
| FY2022 | Dec 31, 2021 | $2.17B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.97B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.57B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $833.95M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $712.18M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $259.76M | Feb 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.79B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.89B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.74B | Feb 12, 2025 |
| FY2024 | Dec 31, 2022 | $1.55B | Feb 12, 2025 |
| FY2022 | Dec 31, 2021 | $1.30B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.21B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $919.31M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $589.31M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $501.82M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $141.06M | Feb 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.91B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.33B | Feb 11, 2026 |
| FY2025 | Dec 31, 2022 | $994.68M | Feb 11, 2026 |
| FY2024 | Dec 31, 2021 | $870.85M | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $762.66M | Feb 14, 2024 |
| FY2022 | Dec 31, 2019 | $649.96M | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | $244.64M | Feb 14, 2022 |
| FY2020 | Dec 31, 2017 | $210.36M | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | $118.70M | Feb 12, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $291.45M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $209.51M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $173.76M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $46.23M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $47.08M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $31.32M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $30.25M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $14.95M | Feb 16, 2021 |
| FY2018 | Dec 31, 2017 | $14.95M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $9.77M | Feb 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($753.90M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($799.81M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | ($804.44M) | Feb 12, 2025 |
| FY2024 | Dec 31, 2022 | ($639.93M) | Feb 12, 2025 |
| FY2022 | Dec 31, 2021 | ($561.00M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | ($483.16M) | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | ($398.13M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($344.38M) | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | ($286.08M) | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | ($245.92M) | Feb 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $882.24M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $512.67M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $387.99M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $331.02M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $377.01M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $378.12M | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $269.67M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $111.49M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $87.68M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $59.70M | Feb 13, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 16, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 16, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 52.56M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 51.77M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 50.45M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 49.22M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | 47.39M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | 46.12M | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | 42.96M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 39.30M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | 37.50M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | 35.78M | Feb 13, 2018 |